Emerging evidences in vivo and in vitro have come to further support the unique, crucial position of GSK-3β in the pathogenesis of AD, especially is the major kinase phosphorylating tau protein, triggering cytoskeleton destabilization, tau aggregation, and neuronal death10. Here, MAPT is linked to Alzheimer disease.